These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcomes After Reirradiation for Recurrent Pediatric Intracranial Ependymoma. Tsang DS; Burghen E; Klimo P; Boop FA; Ellison DW; Merchant TE Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):507-515. PubMed ID: 29229328 [TBL] [Abstract][Full Text] [Related]
3. A Prospective Study of Conventionally Fractionated Dose Constraints for Reirradiation of Primary Brain Tumors in Adults. McGovern SL; Luo D; Johnson J; Nguyen K; Li J; McAleer MF; Yeboa D; Grosshans DR; Ghia AJ; Chung C; Bishop AJ; Song J; Thall PF; Brown PD; Mahajan A Pract Radiat Oncol; 2023; 13(3):231-238. PubMed ID: 36596356 [TBL] [Abstract][Full Text] [Related]
4. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497 [TBL] [Abstract][Full Text] [Related]
5. Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience. Tsang DS; Sarhan N; Ramaswamy V; Nobre L; Yee R; Taylor MD; Hawkins C; Bartels U; Huang A; Tabori U; Hodgson DC; Bouffet E; Laperriere N J Neurooncol; 2019 Oct; 145(1):107-114. PubMed ID: 31468270 [TBL] [Abstract][Full Text] [Related]
6. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature. Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399 [TBL] [Abstract][Full Text] [Related]
10. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience. Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764 [TBL] [Abstract][Full Text] [Related]
11. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review. Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457 [TBL] [Abstract][Full Text] [Related]
12. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation. Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma. Low JS; Chua ET; Gao F; Wee JT Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135 [TBL] [Abstract][Full Text] [Related]
14. Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma. Ohno M; Miyakita Y; Takahashi M; Yanagisawa S; Tamura Y; Kawauchi D; Kikuchi M; Igaki H; Yoshida A; Satomi K; Matsushita Y; Ichimura K; Narita Y Radiat Oncol; 2022 May; 17(1):85. PubMed ID: 35505351 [TBL] [Abstract][Full Text] [Related]
15. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study. Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609 [TBL] [Abstract][Full Text] [Related]
16. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients. Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134 [TBL] [Abstract][Full Text] [Related]
18. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467 [TBL] [Abstract][Full Text] [Related]
19. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653 [TBL] [Abstract][Full Text] [Related]
20. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors. Lee J; Cho J; Chang JH; Suh CO Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]